5434272026-01-012026-03-315434272026-03-315434272025-03-315434272025-04-012026-03-315434272026-01-012026-03-31in-capmkt:OtherExpenses1Member5434272025-04-012026-03-31in-capmkt:OtherExpenses1Member5434272026-03-31OtherNoncurrentFinancialAssetsDomain15434272026-03-31OtherNoncurrentAssetsDomain15434272026-03-31OtherNoncurrentAssetsDomain25434272026-03-31OtherNoncurrentAssetsDomain35434272026-03-31OtherCurrentFinancialAssetsDomain15434272026-03-31OtherCurrentFinancialAssetsDomain25434272026-03-31OtherNoncurrentFinancialLiabilitiesDomain15434272026-03-31OtherNoncurrentFinancialLiabilitiesDomain25434272026-03-31OtherCurrentFinancialLiabilitiesDomain15434272026-03-31OtherCurrentFinancialLiabilitiesDomain25434272026-03-31OtherCurrentLiabilitiesDomain15434272026-03-31OtherCurrentLiabilitiesDomain25434272026-01-012026-03-31in-capmkt:ReportableSegments1Member5434272026-01-012026-03-31in-capmkt:ReportableSegments2Member5434272026-01-012026-03-31in-capmkt:ReportableSegments3Member5434272025-04-012026-03-31in-capmkt:ReportableSegments1Member5434272025-04-012026-03-31in-capmkt:ReportableSegments2Member5434272025-04-012026-03-31in-capmkt:ReportableSegments3Member5434272026-01-012026-03-31in-capmkt:ReportableSegments1Member5434272026-01-012026-03-31in-capmkt:ReportableSegments2Member5434272026-01-012026-03-31in-capmkt:ReportableSegments3Member5434272025-04-012026-03-31in-capmkt:ReportableSegments1Member5434272025-04-012026-03-31in-capmkt:ReportableSegments2Member5434272025-04-012026-03-31in-capmkt:ReportableSegments3Member5434272026-01-012026-03-31in-capmkt:ReportableSegments1Member5434272026-03-31in-capmkt:ReportableSegments1Member5434272026-01-012026-03-31in-capmkt:ReportableSegments2Member5434272026-03-31in-capmkt:ReportableSegments2Member5434272026-01-012026-03-31in-capmkt:ReportableSegments3Member5434272026-03-31in-capmkt:ReportableSegments3Member5434272026-01-012026-03-31in-capmkt:ReportableSegments1Member5434272026-03-31in-capmkt:ReportableSegments1Member5434272026-01-012026-03-31in-capmkt:ReportableSegments2Member5434272026-03-31in-capmkt:ReportableSegments2Member5434272026-01-012026-03-31in-capmkt:ReportableSegments3Member5434272026-03-31in-capmkt:ReportableSegments3Member5434272026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15434272025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15434272026-01-012026-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares543427MEDPLUSNOTLISTEDINE804L01022Medplus Health Services LimitedMain BoardEquity2025-04-012026-03-312026-05-202026-05-03INRMillionsQuarterlyFourth quarterMulti segment2026-05-2014:00:002026-05-2018:30:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated186438500002059500001884980000025625000013951210000-4980200002381170000334800000759470000861500000180463800008034200000803420000223910000-602200001636900000639730000000063973000021710000661440000639830000-100000661540000-10000024011000025.335.33005.335.33000Notes to the Audited consolidated financial results: <BR> 1.The above audited consolidated financial results of MedPlus Health Services Limited ('The Company') and its subsidiaries (together referred as 'The Group') have been prepared in accordance with Indian Accounting Standards ('Ind AS') prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, from time to time. These audited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meetings held on May 20, 2026. These financial results have been audited by the Statutory Auditors of the Company and the auditors have expressed an unqualified opinion on the same. <BR> 2.During the year ended March 31, 2022, the Company has completed its Initial Public Offering (IPO) of 17,573,342 equity shares of face value of Rs. 2 each for cash at an issue price of Rs. 796 per equity share aggregating to Rs. 13,982.95 million, consisting of Fresh Issue of 7,544,511 equity shares amounting to Rs. 6,000.00 million and an offer for sale of 10,028,831 equity shares amounting to Rs. 7,982.95 million by the Selling Shareholders. Pursuant to the IPO, the equity shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) with effect from December 23, 2021. <BR> The utilization of IPO proceeds received by the Company (net of IPO related expense) is summarized below: <BR> Objects as per Prospectus Planned utilisation as per Prospectus Utilisation up to <BR> March 31, 2026 Unutilised amount as on March 31, 2026 <BR> i)Investment in Subsidiary - Optival Health Solutions Private Limited towards their working capital requirements 4,671.70 4,671.70 - <BR> ii)General Corporate Purposes 1,117.63 1,117.63 - <BR> Total 5,789.33 5,789.33 - <BR> 3.During the year ended March 31, 2026, the Central Government of India notified the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the ‘New Labour Codes’, effective from November 21, 2025 primarily impacting the wage definition to be considered for the purpose of defined benefit obligation relating to gratuity and defined benefit contribution relating to leave encashment. <BR> As a result of this plan amendment, the Company’s defined benefit obligation and defined benefit contribution increased by Rs. 34.26 and Rs. 31.06 respectively during the year ended March 31, 2026. A corresponding past service cost was recognized in the statement of profit and loss during the current year. The Company continues to monitor the Central / State Rules as notified and clarifications from the Government on other aspects of the Labour Code and would provide appropriate accounting effect on the basis of such developments as needed. <BR> 4.The results for the quarter ended March are the balancing amounts between the figures in respect of the full financial year and the published figures up to the third quarter of the respective financial year. <BR> 5.The earnings per equity share for the quarters are not annualised. <BR> 6.The above financial results are also available at the Stock Exchange's website i.e. www.bseindia.com, www.nseindia.com and the Company's website www.medplusindia.com. <BR> For and on behalf of the Board of Directors of <BR> MedPlus Health Services Limited <BR> G. Madhukar Reddy <BR> Managing Director & Chief Executive Officer <BR> DIN: 00098097 <BR> Place: Hyderabad <BR> Date: May 20, 20262025-04-012026-03-31AuditedConsolidated689246600007132400006963790000088730000050304700000-345930000884528000012049300002828680000315964000066884600000275330000002753300000776630000-21939000055724000002196060000000021960600002171000022177700002196430000-4300002218200000-4300002401100002018.3318.290018.3318.29000Debt equity ratio of the company is zero, since the company does not have any borrowings as on 31-03-2026 <BR> Debt coverage ratio of the company is zero, since the company does not have any borrowings as on 31-03-2026 <BR> Other Expenses861500000Other Expenses3159640000318361000031980000004145100007879000000000010441600001044160000121248000012385410000186387600001381694000002695900001984120000263750000001977930000686914000042000020686500000393252600002401100001951348000019753590000-7050000197465400000000123497400001234974000033607000012685810000030749000027620100003069500000271217000057816700005903400004926000002830000068929100001957872000039325260000Other financial assets1044160000Other tax assets (net)91100000Other non-current assets25940000Right-of-use assets12268370000Other financial assets1507860000Other current assets470070000Lease liabilities12331240000Other financial liabilities18500000Lease liabilities1912590000Other financial liabilities799580000Other current liabilities179520000Contract liabilities410820000Retail18289760000Diagnostic services347800000Others6290000Retail67601060000Diagnostic services1309870000Others1373000018643850000689246600001864385000068924660000Retail705230000Diagnostic services9640000Others4290000Retail2388110000Diagnostic services17400000Others67200007191600002412230000200000490000-84460000-3415600008034200002753300000Retail31097740000Diagnostic services1377340000Others912000032484200000684106000039325260000Retail18566310000Diagnostic services1011000000Others141000019578720000019578720000490000-36595000000-1066200000-248120000-2575800000000028286800000-214110000357420000199470000000000007390000117602000003377090000613039000000-433680000740900000049558100000016548000016500000000004210000123030000000000000000770731000080734800000000031461000000-1277170000000000993000000002653860000049000000-25550500001123590000011235900008605300001984120000Remeasurement gain on employee benefit plan2691000026910000Remeasurement gain on employee benefit plan269100002691000052000005200000002171000021710000AuditedtrueB S R and Cotrue2029-04-30